The U.S. Food and Drug Administration approved a second test to screen blood, tissue and organ donors for a blood-borne parasite, Trypanosoma cruzi (T. cruzi), that causes Chagas disease, a serious and potentially fatal parasitic infection. The test, called Abbott Prism Chagas [Trypanosoma cruzi (E. coli, Recombinant) Antigen], detects antibodies to T. cruzi. It is a fully automated and highly sensitive and specific test for the detection of antibodies to T. cruzi. The assay is intended as a screen to detect antibodies to T...
More...
More...